Bio-Rad Expands Range of Quality Controls for Abbott Clinical Diagnostics Platforms
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced an expanded portfolio of independent quality controls (QC) products, now including InteliQ and Liquichek compact vials, for the Abbott Alinity ci-series integrated clinical chemistry and immunoassay testing instruments.
